Mark Gurney

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Acute Lymphoblastic Leukemia

Patient Reported

Top Venues

British journal of haematology

Wellcome-HRB ICAT Programme

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wellcome-HRB ICAT Programme Jul 9o 2018

Ireland

Wellcome-HRB ICAT Fellow

Publications

Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun Vinod Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref A Al-Kali
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology (2023)
Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, Christy Finke, Aref A Al-Kali, Naseema Gangat, Mithun Vinod Shah, Hassan B Alkhateeb, Ayalew Tefferi, David A Sallman, Zhuoer Xie, David Viswanatha, Kaaren Reichard, Najla Al Ali, Rami S Komrokji, Eric Padron, Mirinal S Patnaik
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML). Leukemia (2023)
Mark Gurney, Janusz Krawczyk, Yizel E Paz Nuñez
Megakaryocyte emperipolesis in B-lymphoblastic leukaemia. British journal of haematology 188 (3) (2019)
Mark Gurney, Mrinal M Patnaik, Curtis A Hanson, Mark R Litzow, Aref Al-Kali, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities. British journal of haematology 178 (1) (2017)